Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

580
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
580
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

581
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
581
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.6K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse model.

Nature communications·2026
Same author

Reduced plasma TIA-1: bridging established pathology and novel biomarker potential.

Alzheimer's research & therapy·2026
Same author

A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease.

Acta neuropathologica·2026
Same author

Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson's disease.

NPJ Parkinson's disease·2026
Same author

Therapeutic Potential of Amyloid-β Interactors in Rapidly Progressive Alzheimer's Disease-An In Silico Study.

Molecular informatics·2026
Same author

Alterations in cerebrospinal fluid levels of myelin- and oligodendrocyte-related proteins in sporadic Creutzfeldt-Jakob disease.

Acta neuropathologica communications·2026

Related Experiment Video

Updated: Feb 5, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.3K

Diagnostic challenges in rapidly progressive dementia.

Inga Zerr1, Peter Hermann1

  • 1a Clinical Dementia Center and National TSE Reference Center, Department of Neurology , Goettingen University Medical Center , Goettingen , Germany.

Expert Review of Neurotherapeutics
|September 4, 2018
PubMed
Summary

Rapidly progressive dementia diagnosis is challenging due to overlapping symptoms. An extended workup, including immune-mediated diseases and neoplasia, is crucial for identifying treatable conditions.

Keywords:
Dementiadifferential diagnosisencephalitisneurodegenerative diseasesprion diseasesrapidly progressive dementia

More Related Videos

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
07:40

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on: June 29, 2020

14.5K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.9K

Related Experiment Videos

Last Updated: Feb 5, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.3K
Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
07:40

Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications

Published on: June 29, 2020

14.5K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.9K

Area of Science:

  • Neurology
  • Neuroscience
  • Medical Diagnostics

Background:

  • Rapidly progressive dementia (RPD) presents a diagnostic challenge due to diverse etiologies and overlapping clinical features.
  • Accurate diagnosis is critical as many RPD causes are treatable, while others may indicate specific health concerns.
  • The differential diagnosis of RPD is complex, necessitating a thorough and systematic approach.

Purpose of the Study:

  • To review diagnostic and treatment strategies for diseases causing rapid cognitive decline.
  • To interpret current literature within the context of Creutzfeldt-Jakob Disease (CJD) surveillance.
  • To provide an overview of differential diagnoses, diagnostic pitfalls, and therapeutic protocols for RPD.

Main Methods:

  • Comprehensive review of PubMed-listed research articles focusing on RPD diagnosis and treatment.
  • Literature interpretation informed by clinical experience in differentiating RPD, particularly in CJD surveillance.
  • Analysis of inflammatory diseases, rapidly progressive neurodegenerative diseases, toxic-metabolic encephalopathies, and prion diseases.

Main Results:

  • Recent discoveries highlight an increasing number of neurologic disorders, especially immune-mediated diseases, presenting with cognitive symptoms.
  • A significant proportion of RPD cases are potentially treatable, underscoring the need for timely and accurate diagnosis.
  • Diagnostic pitfalls are common, emphasizing the importance of a broad differential diagnosis.

Conclusions:

  • An extended diagnostic workup is recommended for RPD to identify treatable conditions and improve understanding of differential diagnosis and epidemiology.
  • This workup should incorporate standard methods alongside investigations for neoplasia and atypical encephalitis.
  • Consideration of high-dose steroid therapy is advised in specific clinical scenarios, even without clear evidence of inflammation.